Similar articles

• Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus.

  Chan I, Oyama N, Neill SM, Wojnarowska F, Black MM, McGrath JA. Chan I, et al. Clin Exp Dermatol. 2004 Sep;29(5):499-504. doi: 10.1111/j.1365-2230.2004.01573.x. Clin Exp Dermatol. 2004. PMID: 15347336
• Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus.

  Edmonds EV, Oyama N, Chan I, Francis N, McGrath JA, Bunker CB. Edmonds EV, et al. Br J Dermatol. 2011 Jul;165(1):218-9. doi: 10.1111/j.1365-2133.2011.10326.x. Br J Dermatol. 2011. PMID: 21428972 No abstract available.
• Autoantibodies to extracellular matrix protein 1 in lichen sclerosus.

  Oyama N, Chan I, Neill SM, Hamada T, South AP, Wessagowit V, Wojnarowska F, D'Cruz D, Hughes GJ, Black MM, McGrath JA. Oyama N, et al. Lancet. 2003 Jul 12;362(9378):118-23. doi: 10.1016/S0140-6736(03)13863-9. Lancet. 2003. PMID: 12867112
• [Lichen sclerosus. New aspects of pathogenesis and treatment].

  Marini A, Blecken S, Ruzicka T, Hengge UR. Marini A, et al. Hautarzt. 2005 Jun;56(6):550-5. doi: 10.1007/s00105-005-0955-0. Hautarzt. 2005. PMID: 15889230 Review. German.
• [Vulvar lichen sclerosus].

  Moyal-Barracco M. Moyal-Barracco M. Ann Dermatol Venereol. 1997;124(6-7):479-89. Ann Dermatol Venereol. 1997. PMID: 9739916 Review. French. No abstract available.